Plain-English translation of NCT07193914 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a therapy program called ECCCLORE, which was originally designed for people with borderline personality disorder but may also help people dealing with both trauma and addiction. The program combines techniques from cognitive behavioral therapy and acceptance and commitment therapy to address emotional regulation, impulsivity, and trauma-related issues. Researchers want to see if this 6-month program is feasible and acceptable for patients with these co-occurring conditions.
Many people struggle with both trauma and addiction at the same time, and these conditions can make each other worse—particularly through increased impulsivity and substance use. While some treatment programs exist, there is limited evidence about group-based therapies for this combination, so this trial aims to test whether this new treatment can effectively address both problems.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would participate in the ECCCLORE therapy program for 6 months. This is a group-based cognitive behavioral therapy that teaches skills for managing emotions, reducing impulsivity, and processing trauma, with techniques adapted specifically for people struggling with both addiction and trauma. The trial is testing whether this shorter program (compared to longer standard treatments) works well and is acceptable to patients like you.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France